Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse. [electronic resource] by
- Wang, Ying
- Cheon, Dong-Joo
- Lu, Zhen
- Cunningham, Sheena L
- Chen, Chun-Ming
- Luo, Robert Z
- Xing, Deyin
- Orsulic, Sandra
- Bast, Robert C
- Behringer, Richard R
Producer: 20090203
In:
Differentiation; research in biological diversity vol. 76
Availability: No items available.
|
|
15.
|
A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer. [electronic resource] by
- Cheon, Dong-Joo
- Tong, Yunguang
- Sim, Myung-Shin
- Dering, Judy
- Berel, Dror
- Cui, Xiaojiang
- Lester, Jenny
- Beach, Jessica A
- Tighiouart, Mourad
- Walts, Ann E
- Karlan, Beth Y
- Orsulic, Sandra
Producer: 20141006
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
16.
|
Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer. [electronic resource] by
- Nallanthighal, Sameera
- Rada, Miran
- Heiserman, James Patrick
- Cha, Jennifer
- Sage, Jessica
- Zhou, Bo
- Yang, Wei
- Hu, Ye
- Korgaonkar, Chaitali
- Hanos, Christina Terpsithea
- Ashkavand, Zahra
- Norman, Kenneth
- Orsulic, Sandra
- Cheon, Dong-Joo
Producer: 20210329
In:
Cell death & disease vol. 11
Availability: No items available.
|
|
17.
|
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. [electronic resource] by
- Jia, Dongyu
- Liu, Zhenqiu
- Deng, Nan
- Tan, Tuan Zea
- Huang, Ruby Yun-Ju
- Taylor-Harding, Barbie
- Cheon, Dong-Joo
- Lawrenson, Kate
- Wiedemeyer, Wolf R
- Walts, Ann E
- Karlan, Beth Y
- Orsulic, Sandra
Producer: 20170728
In:
Cancer letters vol. 382
Availability: No items available.
|
|
18.
|
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS. [electronic resource] by
- Taylor-Harding, Barbie
- Aspuria, Paul-Joseph
- Agadjanian, Hasmik
- Cheon, Dong-Joo
- Mizuno, Takako
- Greenberg, Danielle
- Allen, Jenieke R
- Spurka, Lindsay
- Funari, Vincent
- Spiteri, Elizabeth
- Wang, Qiang
- Orsulic, Sandra
- Walsh, Christine
- Karlan, Beth Y
- Wiedemeyer, W Ruprecht
Producer: 20151028
In:
Oncotarget vol. 6
Availability: No items available.
|